STAT+: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high

“We’ve lost an opportunity to have direct government purchases of hundreds of thousands of doses of generic Truvada at a lower cost to dramatically lower HIV infections,” said Peter Staley…


ADVERTISEMENT — Advertise With Biotech Networks